Other lipid agents × lipids

TrialEuropean heart journal2012

Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial.

Maartje E Visser et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 2012

No range given

Reported lower lipids, no range given

−18.0percentage points

As reported

difference −18.0 %, no interval

One number in the abstract

the abstract, start to end

LDL-c was reduced by 47 ± 18% (P < 0.001 vs. placebo). apoB

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Lipids
−18.0
Other lipid agentsLipids

Other lipid agents × lipidshelps?mixed

unlikelylikely
0.500.50 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

59 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 22507979